These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25069266)

  • 1. [Role of apolipoprotein E in the molecular pathomechanism of Alzheimer disease].
    Michikawa M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Feb; 34(1):5-9. PubMed ID: 25069266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.
    Liu CC; Liu CC; Kanekiyo T; Xu H; Bu G
    Nat Rev Neurol; 2013 Feb; 9(2):106-18. PubMed ID: 23296339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.
    Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S
    J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of APOE genotype and the presence of Alzheimer's pathology on synaptic membrane lipids of human brains.
    Oikawa N; Hatsuta H; Murayama S; Suzuki A; Yanagisawa K
    J Neurosci Res; 2014 May; 92(5):641-50. PubMed ID: 24446209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E receptor pathways in Alzheimer disease.
    Schmidt V; Carlo AS; Willnow TE
    Wiley Interdiscip Rev Syst Biol Med; 2014; 6(3):255-70. PubMed ID: 24604742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
    Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
    Iurescia S; Fioretti D; Mangialasche F; Rinaldi M
    J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.
    Holtzman DM; Herz J; Bu G
    Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a006312. PubMed ID: 22393530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
    Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of apolipoprotein E in Alzheimer's disease.
    Kim J; Basak JM; Holtzman DM
    Neuron; 2009 Aug; 63(3):287-303. PubMed ID: 19679070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.
    Yamazaki Y; Zhao N; Caulfield TR; Liu CC; Bu G
    Nat Rev Neurol; 2019 Sep; 15(9):501-518. PubMed ID: 31367008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of lipids in Alzheimer's disease.
    Lim WL; Martins IJ; Martins RN
    J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.
    Holtzman DM; Bales KR; Wu S; Bhat P; Parsadanian M; Fagan AM; Chang LK; Sun Y; Paul SM
    J Clin Invest; 1999 Mar; 103(6):R15-R21. PubMed ID: 10079115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Apolipoprotein E Isoforms in Alzheimer's Disease.
    Roda AR; Montoliu-Gaya L; Villegas S
    J Alzheimers Dis; 2019; 68(2):459-471. PubMed ID: 30775980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.